130 related articles for article (PubMed ID: 10913488)
1. Comparison of effects of simvastatin versus atorvastatin on high-density lipoprotein cholesterol and apolipoprotein A-I levels.
Kastelein JJ; Isaacsohn JL; Ose L; Hunninghake DB; Frohlich J; Davidson MH; Habib R; Dujovne CA; Crouse JR; Liu M; Melino MR; O'Grady L; Mercuri M; Mitchel YB
Am J Cardiol; 2000 Jul; 86(2):221-3. PubMed ID: 10913488
[No Abstract] [Full Text] [Related]
2. A comparison of simvastatin and atorvastatin up to maximal recommended doses in a large multicenter randomized clinical trial.
Illingworth DR; Crouse JR; Hunninghake DB; Davidson MH; Escobar ID; Stalenhoef AF; Paragh G; Ma PT; Liu M; Melino MR; O'Grady L; Mercuri M; Mitchel YB;
Curr Med Res Opin; 2001; 17(1):43-50. PubMed ID: 11464446
[TBL] [Abstract][Full Text] [Related]
3. Comparison of once-daily, niacin extended-release/lovastatin with standard doses of atorvastatin and simvastatin (the ADvicor Versus Other Cholesterol-Modulating Agents Trial Evaluation [ADVOCATE]).
Bays HE; Dujovne CA; McGovern ME; White TE; Kashyap ML; Hutcheson AG; Crouse JR;
Am J Cardiol; 2003 Mar; 91(6):667-72. PubMed ID: 12633795
[TBL] [Abstract][Full Text] [Related]
4. Age, abdominal obesity, and baseline high-sensitivity C-reactive protein are associated with low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol, and apolipoprotein B responses to ezetimibe/simvastatin and atorvastatin in patients with metabolic syndrome.
Robinson JG; Ballantyne CM; Hsueh WA; Rosen JB; Lin J; Shah AK; Tomassini JE; Lowe RS; Tershakovec AM
J Clin Lipidol; 2013; 7(4):292-303. PubMed ID: 23890516
[TBL] [Abstract][Full Text] [Related]
5. High-density lipoprotein cholesterol and triglyceride response with simvastatin versus atorvastatin in familial hypercholesterolemia.
Wierzbicki AS; Lumb PJ; Chik G; Crook MA
Am J Cardiol; 2000 Sep; 86(5):547-9, A9. PubMed ID: 11009276
[TBL] [Abstract][Full Text] [Related]
6. Effectiveness of low doses of simvastatin versus atorvastatin: resolving conflicting evidence.
Chong C; Kelly S; Bradley M
Clin Ther; 2002 Feb; 24(2):325-8. PubMed ID: 11911562
[No Abstract] [Full Text] [Related]
7. Dose-response effects of atorvastatin and simvastatin on high-density lipoprotein cholesterol in hypercholesterolaemic patients: a review of five comparative studies.
Wierzbicki AS; Mikhailidis DP
Int J Cardiol; 2002 Jul; 84(1):53-7. PubMed ID: 12104065
[TBL] [Abstract][Full Text] [Related]
8. Effects of high doses of simvastatin and atorvastatin on high-density lipoprotein cholesterol and apolipoprotein A-I.
Crouse JR; Frohlich J; Ose L; Mercuri M; Tobert JA
Am J Cardiol; 1999 May; 83(10):1476-7, A7. PubMed ID: 10335764
[TBL] [Abstract][Full Text] [Related]
9. Effects of simvastatin and atorvastatin in hypercholesterolemic patients.
Bolaman Z; Kadikoylu G
Clin Ther; 2003 Oct; 25(10):2631-3. PubMed ID: 14667963
[No Abstract] [Full Text] [Related]
10. High-dose atorvastatin therapy in severe heterozygous familial hypercholesterolaemia.
Wierzbicki AS; Lumb PJ; Semra YK; Crook MA
QJM; 1998 Apr; 91(4):291-4. PubMed ID: 9666952
[TBL] [Abstract][Full Text] [Related]
11. Lipid-altering efficacy and safety of ezetimibe/simvastatin versus atorvastatin in patients with hypercholesterolemia and the metabolic syndrome (from the VYMET study).
Robinson JG; Ballantyne CM; Grundy SM; Hsueh WA; Parving HH; Rosen JB; Adewale AJ; Polis AB; Tomassini JE; Tershakovec AM
Am J Cardiol; 2009 Jun; 103(12):1694-702. PubMed ID: 19539078
[TBL] [Abstract][Full Text] [Related]
12. HDL-cholesterol and the treatment of coronary heart disease: contrasting effects of atorvastatin and simvastatin.
Mikhailidis DP; Wierzbicki AS
Curr Med Res Opin; 2000; 16(2):139-46. PubMed ID: 10893658
[TBL] [Abstract][Full Text] [Related]
13. Safety and efficacy of ezetimibe/simvastatin combination versus atorvastatin alone in adults ≥65 years of age with hypercholesterolemia and with or at moderately high/high risk for coronary heart disease (the VYTELD study).
Foody JM; Brown WV; Zieve F; Adewale AJ; Flaim D; Lowe RS; Jones-Burton C; Tershakovec AM
Am J Cardiol; 2010 Nov; 106(9):1255-63. PubMed ID: 21029821
[TBL] [Abstract][Full Text] [Related]
14. Once-daily niacin extended release/lovastatin combination tablet has more favorable effects on lipoprotein particle size and subclass distribution than atorvastatin and simvastatin.
Bays HE; McGovern ME
Prev Cardiol; 2003; 6(4):179-88. PubMed ID: 14605511
[TBL] [Abstract][Full Text] [Related]
15. Achievement of specified low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol apolipoprotein B, and high-sensitivity C-reactive protein levels with ezetimibe/simvastatin or atorvastatin in metabolic syndrome patients with and without atherosclerotic vascular disease (from the VYMET study).
Robinson JG; Ballantyne CM; Hsueh W; Rosen J; Lin J; Shah A; Lowe RS; Hanson ME; Tershakovec AM
J Clin Lipidol; 2011; 5(6):474-82. PubMed ID: 22108151
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the impact of atorvastatin and simvastatin on apoA-I kinetics in men.
Mauger JF; Couture P; Paradis ME; Lamarche B
Atherosclerosis; 2005 Jan; 178(1):157-63. PubMed ID: 15585213
[TBL] [Abstract][Full Text] [Related]
17. No difference in plasma fibrinogen levels between CAPD patients taking atorvastatin and simvastatin.
Singhal MK; Bhaskaran S; Szabo T; La Rosa R
Perit Dial Int; 1999; 19(1):89-91. PubMed ID: 10201354
[No Abstract] [Full Text] [Related]
18. Comparing the efficacy and safety of atorvastatin and simvastatin in Asians with elevated low-density lipoprotein-cholesterol--a multinational, multicenter, double-blind study.
Wu CC; Sy R; Tanphaichitr V; Hin AT; Suyono S; Lee YT
J Formos Med Assoc; 2002 Jul; 101(7):478-87. PubMed ID: 12353340
[TBL] [Abstract][Full Text] [Related]
19. Combination of niacin extended-release and simvastatin results in a less atherogenic lipid profile than atorvastatin monotherapy.
Insull W; Toth PP; Superko HR; Thakkar RB; Krause S; Jiang P; Parreno RA; Padley RJ
Vasc Health Risk Manag; 2010 Nov; 6():1065-75. PubMed ID: 21191426
[TBL] [Abstract][Full Text] [Related]
20. Differential regulation of lipoprotein kinetics by atorvastatin and fenofibrate in subjects with the metabolic syndrome.
Watts GF; Barrett PH; Ji J; Serone AP; Chan DC; Croft KD; Loehrer F; Johnson AG
Diabetes; 2003 Mar; 52(3):803-11. PubMed ID: 12606523
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
